作者
- Clegg, J. (4)
- Emanuelsson, H. (14)
- Gilchrist, I.C. (4)
- Greenbaum, A.B. (6)
- Grines, C.L. (4)
- Grogan, D.R. (4)
- Harrington, R.A. (4)
- Kereiakes, D.J. (4)
- Stankowski, J.E. (6)
- Weaver, W.D. (6)
|
總筆數:14
| 篇名 | 作者 | 刊名 | 出版年 | 查看 |
|---|
| Randomized double-blind Scandinavian trial of angiopeptin versus placebofor the prevention of clinical events and restenosis after coronary balloonangioplasty |
Eriksen, U.H.;Amtorp, O.;Bagger, J.P.;Emanuelsson, H.;Foegh, M.;Henningsen, P.;Saunamaki, K.;Schaeffer, M.;Thayssen, P.;Orskov, H.;Kuntz, R.E.;Popma, J.J.; |
American Heart Journal |
1995-07-01 |
查看 |
| Effects of the new calcium antagonist mibefradil (Ro 40-5967) on exerciseduration in patients with chronic stable angina pectoris: A multicenter,placebo-controlled study |
Bakx, A.L.M.;van der Wall, E.E.;Braun, S.;Emanuelsson, H.;Bruschke, A.V.G.;Kobrin, I.; |
American Heart Journal |
1995-10-01 |
查看 |
| Use of abciximab in interventional cardiology |
Chronos, N.;Vahanian, A.;Betriu, A.;Emanuelsson, H.;Goldberg, S.;Gulba, D.;van Hout, B.A.; |
American Heart Journal |
1998-04-01 |
查看 |
| Antianginal efficacy of the combination of felodipine-metoprolol 10/100mg compared with each drug alone in patients with stable effort-inducedangina pectoris: A multicenter parallel group study |
For the TRAFFIC Study Group;Emanuelsson, H.;Egstrup, K.;Nikus, K.;Ellstrom, J.;Glud, T.;Pater, C.;Scheibel, M.;Tisell, A.;Totterman, K.J.;Forsby, M.; |
American Heart Journal |
1999-05-01 |
查看 |
| Antianginal efficacy of the combination of felodipine-metoprolol 10/100mg compared with each drug alone in patients with stable effort-inducedangina pectoris: A multicenter parallel group study |
For the TRAFFIC Study Group;Emanuelsson, H.;Egstrup, K.;Nikus, K.;Ellstrom, J.;Glud, T.;Pater, C.;Scheibel, M.;Tisell, A.;Totterman, K.J.;Forsby, M.; |
American Heart Journal |
1999-05-01 |
查看 |
| Antianginal efficacy of the combination of felodipine-metoprolol 10/100mg compared with each drug alone in patients with stable effort-inducedangina pectoris: A multicenter parallel group study |
For the TRAFFIC Study Group;Emanuelsson, H.;Egstrup, K.;Nikus, K.;Ellstrom, J.;Glud, T.;Pater, C.;Scheibel, M.;Tisell, A.;Totterman, K.J.;Forsby, M.; |
American Heart Journal |
1999-05-01 |
查看 |
| Initial experience with an intravenous P2Y"1"2 platelet receptorantagonist in patients undergoing percutaneous coronary intervention:Results from a 2-part, phase II, multicenter, randomized, placebo- andactive-controlled trial |
Greenbaum, A.B.;Grines, C.L.;Bittl, J.A.;Becker, R.C.;Kereiakes, D.J.;Gilchrist, I.C.;Clegg, J.;Stankowski, J.E.;Grogan, D.R.;Harrington, R.A.;Emanuelsson, H.;Weaver, W.D.; |
American Heart Journal |
2006-03-01 |
查看 |
| Initial experience with an intravenous P2Y"1"2 platelet receptorantagonist in patients undergoing percutaneous coronary intervention:Results from a 2-part, phase II, multicenter, randomized, placebo- andactive-controlled trial |
Greenbaum, A.B.;Grines, C.L.;Bittl, J.A.;Becker, R.C.;Kereiakes, D.J.;Gilchrist, I.C.;Clegg, J.;Stankowski, J.E.;Grogan, D.R.;Harrington, R.A.;Emanuelsson, H.;Weaver, W.D.; |
American Heart Journal |
2006-03-01 |
查看 |
| Initial experience with an intravenous P2Y"1"2 platelet receptorantagonist in patients undergoing percutaneous coronary intervention:Results from a 2-part, phase II, multicenter, randomized, placebo- andactive-controlled trial |
Greenbaum, A.B.;Grines, C.L.;Bittl, J.A.;Becker, R.C.;Kereiakes, D.J.;Gilchrist, I.C.;Clegg, J.;Stankowski, J.E.;Grogan, D.R.;Harrington, R.A.;Emanuelsson, H.;Weaver, W.D.; |
American Heart Journal |
2006-03-01 |
查看 |
| Initial experience with an intravenous P2Y"1"2 platelet receptorantagonist in patients undergoing percutaneous coronary intervention:Results from a 2-part, phase II, multicenter, randomized, placebo- andactive-controlled trial |
Greenbaum, A.B.;Grines, C.L.;Bittl, J.A.;Becker, R.C.;Kereiakes, D.J.;Gilchrist, I.C.;Clegg, J.;Stankowski, J.E.;Grogan, D.R.;Harrington, R.A.;Emanuelsson, H.;Weaver, W.D.; |
American Heart Journal |
2006-03-01 |
查看 |
| Preliminary experience with intravenous P2Y"1"2 platelet receptorinhibition as an adjunct to reduced-dose alteplase during acute myocardialinfarction: Results of the Safety, Tolerability and Effect on Patency inAcute Myocardial Infarction (STEP-AMI) angiographic trial |
Greenbaum, A.B.;Ohman, E.M.;Gibson, C.M.;Borzak, S.;Stebbins, A.L.;Lu, M.;Le May, M.R.;Stankowski, J.E.;Emanuelsson, H.;Weaver, W.D.; |
American Heart Journal |
2007-10-01 |
查看 |
| Preliminary experience with intravenous P2Y"1"2 platelet receptorinhibition as an adjunct to reduced-dose alteplase during acute myocardialinfarction: Results of the Safety, Tolerability and Effect on Patency inAcute Myocardial Infarction (STEP-AMI) angiographic trial |
Greenbaum, A.B.;Ohman, E.M.;Gibson, C.M.;Borzak, S.;Stebbins, A.L.;Lu, M.;Le May, M.R.;Stankowski, J.E.;Emanuelsson, H.;Weaver, W.D.; |
American Heart Journal |
2007-10-01 |
查看 |
| Effect of ximelagatran on ischemic events and death in patients withatrial fibrillation after acute myocardial infarction in the efficacy andsafety of the oral direct thrombin inhibitor ximelagatran in patients withrecent myocardial damage (ESTEEM) trial |
Tangelder, M.J.D.;Frison, L.;Weaver, D.;Wilcox, R.G.;Bylock, A.;Emanuelsson, H.;Held, P.;Oldgren, J.; |
American Heart Journal |
2008-02-01 |
查看 |
| Effect of ximelagatran on ischemic events and death in patients withatrial fibrillation after acute myocardial infarction in the efficacy andsafety of the oral direct thrombin inhibitor ximelagatran in patients withrecent myocardial damage (ESTEEM) trial |
Tangelder, M.J.D.;Frison, L.;Weaver, D.;Wilcox, R.G.;Bylock, A.;Emanuelsson, H.;Held, P.;Oldgren, J.; |
American Heart Journal |
2008-02-01 |
查看 |
|
|
|
